IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
NCT01288963
·
clinicaltrials.gov ↗
COMPLETED
Status
153
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma
Interventions
DRUG:
IL-2
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
[object Object]